Sirio Pharma Co.Ltd(300791) : announcement of the resolution of the fifth meeting of the third board of supervisors

Securities code: 300791 securities abbreviation: Sirio Pharma Co.Ltd(300791) announcement Code: 2022-002 securities code: 123113 securities abbreviation: xianle convertible bonds

Sirio Pharma Co.Ltd(300791)

Announcement on the resolution of the fifth meeting of the third board of supervisors

1、 Meetings of the board of supervisors

The fifth meeting of the third board of supervisors of Sirio Pharma Co.Ltd(300791) (hereinafter referred to as "the company") was held in the company's conference room at No. 83, Taishan Road, Longhu District, Shantou City on Monday, January 24, 2022 by combining on-site and communication voting. The notice of the meeting was delivered to all supervisors by e-mail, wechat information and other means on January 18, 2022. There are 3 supervisors who should attend the meeting and 3 supervisors who actually attended the meeting. The meeting was convened and held in accordance with the relevant provisions of the company law of the people's Republic of China, the articles of association of Sirio Pharma Co.Ltd(300791) and the rules of procedure of Sirio Pharma Co.Ltd(300791) board of supervisors, and the meeting was legal and valid.

2、 Deliberation at the meeting of the board of supervisors

After careful deliberation by the supervisors attending the meeting, the following resolutions were adopted item by item in the way of recovering votes:

1. The proposal on estimated daily connected transactions in 2022 was deliberated and adopted

After deliberation, the board of supervisors believes that this daily connected transaction is the normal business behavior of the company and is required for the daily production and operation of the company. It will follow the principles of fairness, impartiality and openness, based on the fair market price, and there is no situation that damages the interests of the company and all shareholders.

For details, please refer to the announcement on the expected daily connected transactions of the company in 2022 published on the gem information disclosure website designated by the CSRC.

Voting results: 3 votes in favor; No negative vote; There were no abstentions.

2. The proposal on Amending the decision-making system of connected transactions was considered and adopted

In accordance with the company law, the securities law, the guidelines for the articles of association of listed companies and the Listing Rules of Shenzhen Stock Exchange gem According to the latest provisions of relevant laws, regulations and normative documents such as self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 - standardized operation of companies listed on GEM and self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 5 - management of information disclosure affairs, and in combination with the actual situation of the company, The company revised the decision-making system of related party transactions accordingly.

The revised contents are detailed in the decision-making system for connected transactions published on the gem information disclosure website designated by the CSRC on the same day.

Voting results: 3 in favor, 0 against and 0 abstention.

This proposal still needs to be submitted to the first extraordinary general meeting of shareholders of the company in 2022 for deliberation.

3. The proposal on Amending the rules of procedure of the board of supervisors was deliberated and adopted

In accordance with the company law, the securities law, the guidelines for the articles of association of listed companies and the Listing Rules of Shenzhen Stock Exchange gem According to the latest provisions of relevant laws, regulations and normative documents such as self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 - standardized operation of companies listed on GEM and self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 5 - management of information disclosure affairs, and in combination with the actual situation of the company, The company amended the rules of procedure of the board of supervisors accordingly.

The revised contents are detailed in the rules of procedure of the board of supervisors published on the gem information disclosure website designated by the CSRC on the same day.

Voting results: 3 in favor, 0 against and 0 abstention.

This proposal still needs to be submitted to the first extraordinary general meeting of shareholders of the company in 2022 for deliberation.

3、 Documents for future reference

1. Sirio Pharma Co.Ltd(300791) resolution of the fifth meeting of the third board of supervisors.

It is hereby announced.

Sirio Pharma Co.Ltd(300791) board of supervisors

January 24, 2002

- Advertisment -